| A CFTR potentiator in patients with cystic fibrosis and the G551D mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011 | 2256 | 2011 |
| Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation FJ Accurso, SM Rowe, JP Clancy, MP Boyle, JM Dunitz, PR Durie, ... New England Journal of Medicine 363 (21), 1991-2003, 2010 | 878 | 2010 |
| Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria R Agarwal, A Chakrabarti, A Shah, D Gupta, JF Meis, R Guleria, R Moss, ... Clinical & Experimental Allergy 43 (8), 850-873, 2013 | 796 | 2013 |
| Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: Cystic Fibrosis Foundation Consensus Conference DA Stevens, RB Moss, VP Kurup, AP Knutsen, P Greenberger, ... Clinical Infectious Diseases 37 (Supplement_3), S225-S264, 2003 | 787 | 2003 |
| Late pulmonary sequelae of bronchopulmonary dysplasia WH Northway Jr, RB Moss, KB Carlisle, BR Parker, RL Popp, PT Pitlick, ... New England Journal of Medicine 323 (26), 1793-1799, 1990 | 690 | 1990 |
| Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation JP Clancy, SM Rowe, FJ Accurso, ML Aitken, RS Amin, MA Ashlock, ... Thorax 67 (1), 12-18, 2012 | 634 | 2012 |
| Fungi and allergic lower respiratory tract diseases AP Knutsen, RK Bush, JG Demain, DW Denning, A Dixit, A Fairs, ... Journal of Allergy and Clinical Immunology 129 (2), 280-291, 2012 | 551 | 2012 |
| Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter … RB Moss, D Rodman, LT Spencer, ML Aitken, PL Zeitlin, D Waltz, C Milla, ... Chest 125 (2), 509-521, 2004 | 465 | 2004 |
| Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis RL Gibson, J Emerson, S McNamara, JL Burns, M Rosenfeld, A Yunker, ... American journal of respiratory and critical care medicine 167 (6), 841-849, 2003 | 376 | 2003 |
| High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis R Tirouvanziam, CK Conrad, T Bottiglieri, LA Herzenberg, RB Moss, ... Proceedings of the National Academy of Sciences 103 (12), 4628-4633, 2006 | 326 | 2006 |
| Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial RB Moss, C Milla, J Colombo, F Accurso, PL Zeitlin, JP Clancy, ... Human gene therapy 18 (8), 726-732, 2007 | 314 | 2007 |
| A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies JA Wagner, IB Nepomuceno, AH Messner, ML Moran, EP Batson, ... Human gene therapy 13 (11), 1349-1359, 2002 | 304 | 2002 |
| Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR … MW Konstan, EF McKone, RB Moss, G Marigowda, S Tian, D Waltz, ... The lancet Respiratory medicine 5 (2), 107-118, 2017 | 286 | 2017 |
| A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease ML Aitken, RB Moss, DA Waltz, ME Dovey, MR Tonelli, SC McNamara, ... Human gene therapy 12 (15), 1907-1916, 2001 | 273 | 2001 |
| Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus JA Wagner, T Reynolds, ML Moran, RB Moss, JJ Wine, TR Flotte, ... The Lancet 351 (9117), 1702-1703, 1998 | 270 | 1998 |
| Safety and Biological Efficacy of an Adeno‐Associated Virus Vector–Cystic Fibrosis Transmembrane Regulator (AAV‐CFTR) in the Cystic Fibrosis Maxillary Sinus JA Wagner, AH Messner, ML Moran, R Daifuku, K Kouyama, JK Desch, ... The Laryngoscope 109 (2), 266-274, 1999 | 244 | 1999 |
| Alternative approach to Allergies TH Randolph Bantam Books, 1982 | 230 | 1982 |
| Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol LA Lange, Y Hu, H Zhang, C Xue, EM Schmidt, ZZ Tang, C Bizon, ... The American Journal of Human Genetics 94 (2), 233-245, 2014 | 225 | 2014 |
| Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy MJ Reid, RB Moss, YP Hsu, JM Kwasnicki, TM Commerford, BL Nelson Journal of allergy and clinical immunology 78 (4), 590-600, 1986 | 225 | 1986 |
| Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial RB Moss, PA Flume, JS Elborn, J Cooke, SM Rowe, SA McColley, ... The Lancet Respiratory Medicine 3 (7), 524-533, 2015 | 215 | 2015 |
Michael KonstanCase Western Reserve University School of Medicine在 case.edu 的电子邮件经过验证
